GBIO vs USB · rev $19.9M vs P/E 12, rev $7.71B
Generation Bio Co (GBIO) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Generation Bio Co (GBIO) is a biotechnology company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported GBIO revenue for 2024-12-31 was $19.9M. Net income was -$131.7M. Revenue was up 236.9% from 2023-12-31 to 2024-12-31. GBIO currently screens at market cap $25.4M.
Latest reported USB revenue for 2026-06-30 was $7.71B. Net income was $2.18B. Revenue was up 5.8% from 2026-03-31 to 2026-06-30. USB currently screens at market cap $74.68B and trailing P/E 11.9.
GBIO currently screens at market cap $25.4M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the GBIO and USB stock pages for the full models.
Not investment advice.